FINDINGS
CTT Collaboration analyses have determined the effects of statin therapy on major vascular events and vascular mortality for trials of:
CTT Collaboration analyses have shown that statins are beneficial in a wide range of individuals, including:
- people with diabetes
- people at low risk of vascular disease
- women and men
- people of all ages, including those over the age of 75
- being clearly effective at reducing cardiovascular risk in patients with mild-to-moderate chronic kidney disease (CKD), but relative benefits may be smaller as CKD becomes advanced, with little evidence of benefit among those already on dialysis
In addition CTT Collaboration analyses have shown that statins have:
